Arrowstreet Capital
ELAN icon

Arrowstreet Capital’s Elanco Animal Health ELAN Stock Holding History

Arrowstreet Capital’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.1M Buy
1,872,157
+1,023,785
+121% +$23.7M 0.02% 599
2026
Q1 		$20.3M Buy
848,372
+641,448
+310% +$15.7M 0.01% 750
2025
Q4 		$4.68M Buy
+206,924
New +$4.5M ﹤0.01% 1157
2025
Q3 		– Sell
-310,383
Closed -$4.43M – 1939
2025
Q2 		$4.43M Buy
310,383
+295,651
+2,007% +$3.46M ﹤0.01% 1215
2025
Q1 		$155K Buy
+14,732
New +$167K ﹤0.01% 1751
2024
Q4 		– Sell
-25,677
Closed -$377K – 1795
2024
Q3 		$377K Buy
25,677
+2,563
+11% +$35.7K ﹤0.01% 1563
2024
Q2 		$334K Buy
+23,114
New +$369K ﹤0.01% 1384
2023
Q2 		– Sell
-165,703
Closed -$1.56M – 1287
2023
Q1 		$1.56M Sell
165,703
-435,596
-72% -$5.14M ﹤0.01% 968
2022
Q4 		$7.35M Buy
601,299
+260,171
+76% +$3.24M 0.01% 594
2022
Q3 		$4.23M Buy
341,128
+133,969
+65% +$2.34M 0.01% 691
2022
Q2 		$4.07M Buy
207,159
+128,439
+163% +$3.04M 0.01% 643
2022
Q1 		$2.05M Buy
78,720
+35,535
+82% +$946K ﹤0.01% 803
2021
Q4 		$1.23M Buy
+43,185
New +$1.34M ﹤0.01% 1119
2021
Q3 		– Sell
-5,980
Closed -$207K – 1657
2021
Q2 		$207K Buy
+5,980
New +$197K ﹤0.01% 1782
2021
Q1 		– Sell
-6,900
Closed -$212K – 2309
2020
Q4 		$212K Buy
+6,900
New +$211K ﹤0.01% 2180
2020
Q3 		– Sell
-70,300
Closed -$1.51M – 2374
2020
Q2 		$1.51M Sell
70,300
-1,093,025
-94% -$24.1M ﹤0.01% 1598
2020
Q1 		$26M Sell
1,163,325
-192,893
-14% -$5.28M 0.07% 242
2019
Q4 		$39.9M Buy
1,356,218
+561,568
+71% +$15.3M 0.09% 215
2019
Q3 		$21.1M Buy
+794,650
New +$23.8M 0.05% 333
2019
Q2 		– Sell
-176,840
Closed -$5.67M – 1467
2019
Q1 		$5.67M Buy
+176,840
New +$5.44M 0.01% 745

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Arrowstreet Capital's ELAN Position: Q2 2026 in Review

Arrowstreet Capital increased its Elanco Animal Health (ELAN) stake by 121% in Q2 2026, buying an estimated $23.7M and bringing the position to 1,872,157 shares worth $46.1M. The position accounts for 0.02% of the portfolio, ranked #599.

Arrowstreet Capital first reported a position in ELAN in Q1 2019 and has held it in 20 quarters since. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Arrowstreet Capital held 1,872,157 shares of Elanco Animal Health worth $46.1M as of Q2 2026.
  • Arrowstreet Capital bought 1,023,785 Elanco Animal Health shares in Q2 2026, an estimated $23.7M.
  • Elanco Animal Health made up 0.02% of Arrowstreet Capital's portfolio in Q2 2026, its #599 holding.
  • Arrowstreet Capital first reported a position in Elanco Animal Health in Q1 2019 and has held it in 20 quarters since.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.